Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs NWSA✓SelectedUSD · NWSAGSK vs NWSA performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs NWSA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
NWSA return
+21.7%
Excess return
+31.0%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioNWSAExcessAlpha
1D-0.1%-1.0%+0.9%0.0%
7D-5.3%-7.1%+1.8%-4.4%
30D-3.7%-17.7%+14.0%-1.2%
3M-7.3%-15.2%+8.0%-5.2%
6M-4.2%-2.5%-1.8%-3.5%
YTD+0.9%-3.4%+4.2%+1.7%
1Y+7.3%+1.8%+5.5%+7.5%
3Y+52.7%+20.4%+32.4%+51.2%
All+52.7%+21.7%+31.0%+51.2%

Cumulative growth

Daily Returns

Daily percentage return beside NWSA.

Daily Out/Under-Performance

Portfolio return minus NWSA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NWSA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded NWSA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling